Deep Track Capital, LP 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:36 am Sale | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital, LP | 0 0.000% | -1,816,531 (Position Closed) | Filing |
| 2023-02-14 08:27 am Unchanged | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital, LP | 1,816,531 6.610% | 0 (Unchanged) | Filing |
| 2022-12-22 4:02 pm Purchase | 2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Capital, LP | 1,816,531 7.320% | 1,816,531 (New Position) | Filing |